Pr. Marc AURIACOMBE

Publications



Articles

2023

  1. Chapron, S-A.; Kervran, C.; Da Rosa, M.; Fournet, L.; Shmulewitz, D.; Hasin, D.; Denis, C.; Collombat, J.; Monsaingeon, M.; Fatseas, M.; Gatta-Cherifi, B.; Serre, F. et al. Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample. In Drug and Alcohol Dependence, 251: 110937, 2023. doi 
  2. Chirokoff, V.; Dupuy, M.; Abdallah, M.; Fatseas, M.; Serre, F.; Auriacombe, M.; Misdrahi, D.; Berthoz, S.; Swendsen, J.; Sullivan, E. V. and Chanraud, S. Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders. In Addiction Neuroscience, 9: 100138, 2023. doi 
  3. David, J-C.; Fonte, D.; Sutter-Dallay, A-L.; Auriacombe, M.; Serre, F.; Rascle, N. and Loyal, D. The stigma of smoking among women: A systematic review. In Social Science & Medicine, 340: 116491, 2023. doi 
  4. Dora, J.; Piccirillo, M.; Foster, K. T.; Arbeau, K.; Armeli, S.; Auriacombe, M.; Bartholow, B.; Beltz, A. M.; Blumenstock, S. M.; Bold, K.; Bonar, E. E.; Braitman, A. et al. The daily association between affect and alcohol use: A meta-analysis of individual participant data. In Psychological Bulletin, 149 (1-2): 1-24, 2023. doi 
  5. Gauld, C.; Baillet, E.; Micoulaud-Franchi, J-A.; Kervran, C.; Serre, F. and Auriacombe, M. The centrality of craving in network analysis of five substance use disorders. In Drug and Alcohol Dependence, 245: 109828, 2023. doi 
  6. Geoffroy, P.A.; Schroder, C.M.; Bourgin, P.; Maruani, J.; Lejoyeux, M.; D'Ortho, M.-P.; Couffignal, C.; Philip, P.; Arnulf, I.; Royant-Parola, S.; Leger, D.; Gohier, B. et al. Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort. In L'Encéphale, 49 (2): 117-123, 2023. doi 
  7. Lalanne, L.; Roux, P.; Donadille, C.; Briand Madrid, L.; Célerier, I.; Chauvin, C.; Hamelin, N.; Kervran, C.; Maradan, G.; Auriacombe, M. and Jauffret‐Roustide, M. Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study. In Addiction, 2023. doi 
  8. Loyal, D.; Sutter, A.-L.; Auriacombe, M.; Serre, F. and Rascle, N. The Pregnant Smoker Stigma Scale - Self Stigma (P3S-SS): development and validation in pregnant smoking women in France. In Women & Health, 63 (7): 507-517, 2023. doi 
  9. Martin-Fernandez, J.; Perrin, S.; Stevens, N.; Moriceau, S.; Serre, F.; Auriacombe, M.; France, S. and Cambon, L. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support program based on mental health recovery: the vitae study: First results. In Population Medicine, 5 (Supplement), 2023. doi 
  10. Morawetz, C.; Berboth, S.; Chirokoff, V.; Chanraud, S.; Misdrahi, D.; Serre, F.; Auriacombe, M.; Fatseas, M. and Swendsen, J. Mood Variability, Craving, and Substance Use Disorders: From Intrinsic Brain Network Connectivity to Daily Life Experience. In Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 8 (9): 940-955, 2023. doi 
  11. Sanchez-Ortuno, M. M.; Pecune, F.; Coelho, J.; Micoulaud-Franchi, J. A.; Salles, N.; Auriacombe, M.; Serre, F.; Levavasseur, Y.; de Sevin, E.; Sagaspe, P. and Philip, P. Predictors of users' adherence to a fully automated digital intervention to manage insomnia complaints. In Journal of the American Medical Informatics Association, 2023. doi 
  12. Serre, F.; Moriceau, S.; Donnadieu, L.; Forcier, C.; Garnier, H.; Alexandre, J-M.; Dupuy, L.; Philip, P.; Levavasseur, Y.; de Sevin, E. and Auriacombe, M. The Craving-Manager smartphone app designed to diagnose substance use/addictive disorders, and manage craving and individual predictors of relapse: a study protocol for a multicenter randomized controlled trial. In Frontiers in Psychiatry, 14, 2023. doi 

2022

  1. Barrault-Couchouron, M.; Béracochéa, M.; Dorval, M.; Allafort, V.; Barthélémy, V.; Garguil, V.; Auriacombe, M.; Bussières, E. and M'bailara, K. Consommations de tabac et d'alcool chez des femmes traitées pour un cancer du sein dans un service de chirurgie oncologique : des comportements fréquents à considérer. In Bulletin du Cancer, 109 (3): 307-317, 2022. doi 
  2. Boudard, M.; Alexandre, J-M.; Kervran, C.; Jakubiec, L.; Shmulewitz, D.; Hasin, D.; Fournet, L.; Rassis, C.; Claverie, P.; Serre, F. and Auriacombe, M. Item Response Theory Analyses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Criteria Adapted to Screen Use Disorder: Exploratory Survey. In Journal of Medical Internet Research, 24 (7): e31803, 2022. doi 
  3. Dupuy, L.; Morin, C. M.; de Sevin, E.; Taillard, J.; Salles, N.; Bioulac, S.; Auriacombe, M.; Micoulaud‐Franchi, J. and Philip, P. Smartphone‐based virtual agents and insomnia management: A proof‐of‐concept study for new methods of autonomous screening and management of insomnia symptoms in the general population. In Journal of Sleep Research, 31 (2), 2022. doi 
  4. Egal, A.; Donon, C.; Jakubiec, L.; Lambert, L.; Fatseas, M. and Auriacombe, M. Ordalie, recherche de sensations et impulsivité. Analyse critique des définitions. In L'Encéphale, 48 (2): 163-170, 2022. doi 
  5. Jakubiec, L.; Chirokoff, V.; Abdallah, M.; Sanz-Arigita, E.; Dupuy, M.; Swendsen, J.; Berthoz, S.; Gierski, F.; Guionnet, S.; Misdrahi, D.; Serre, F.; Auriacombe, M. et al. The Executive Functioning Paradox in Substance Use Disorders. In Biomedicines, 10 (11): 2728, 2022. doi 
  6. Jean, F. A. M.; Arsandaux, J.; Montagni, I.; Collet, O.; Fatséas, M.; Auriacombe, M.; Ramos-Quiroga, J. A.; Côté, S. M.; Tzourio, C. and Galéra, C. Attention deficit hyperactivity disorder symptoms and cannabis use after 1 year among students of the i-Share cohort. In European Psychiatry, 65 (1): e25, 2022. doi 
  7. Lambert, L.; Serre, F.; Thirioux, B.; Jaafari, N. and Auriacombe, M. Clinical insight level predicts successful quit or control attempts during the first three months of outpatient addiction treatment. In Drug and Alcohol Dependence, 234: 109391, 2022. doi 
  8. Lambert, L.; Serre, F.; Thirioux, B.; Jaafari, N.; Roux, P.; Jauffret-Roustide, M.; Lalanne, L.; Daulouède, J-P. and Auriacombe, M. Link Between Perception of Treatment Need and Craving Reports in Addiction. In Frontiers in Psychiatry, 12, 2022. doi 
  9. Laviec, N.; Perino, J.; Paillou, V.; Titier, K.; Benali, L.; Dumestre, V.; Daulouède, J-P.; Latour, V.; Auriacombe, M.; Fouilhé, N.; Miremont-Salamé, G. and Daveluy, A. Décès après consommation de substances psychoactives entre 2018 à 2020 en Aquitaine et Départements et Régions d'Outre-Mer. In Therapies, 77 (6): 769-770, 2022. doi 
  10. Loyal, D.; Sutter, A-L.; Auriacombe, M.; Serre, F.; Calcagni, N. and Rascle, N. Stigma Attached to Smoking Pregnant Women: A Qualitative Insight in the General French Population. In Nicotine & Tobacco Research, 24 (2): 257-264, 2022. doi 
  11. Loyal, D.; Sutter, A-L.; Auriacombe, M.; Serre, F. and Rascle, N. The Pregnant Smoker Stigma Scale – Public Stigma (P3S-PS): development and validation in general French population. In Women & Health, 62 (2): 157-167, 2022. doi 
  12. Martin-Fernandez, J.; Stevens, N.; Moriceau, S.; Serre, F.; Blanc, H.; Latourte, E.; Auriacombe, M. and Cambon, L. Realist evaluation of the impact, viability and transferability of an alcohol harm reduction support programme based on mental health recovery: the Vitae study protocol. In BMJ Open, 12 (8): e065361, 2022. doi 
  13. Phiilip, P.; Dupuy, L.; de Sevin, E.; Taillard, J.; Morin, C.; Auriacombes, M. and Micoulaud-Franchi, J-A. KANOPEE : efficacité d'une solution numérique autonome dans la prise en charge des plaintes d'insomnies en population générale. In Médecine du Sommeil, 19 (1): 30-31, 2022. doi 
  14. Philip, P.; Dupuy, L.; Sagaspe, P.; de Sevin, E.; Auriacombe, M.; Taillard, J.; Micoulaud-Franchi, J-A. and Morin, C. M. Efficacy of a Smartphone-Based Virtual Companion to Treat Insomniac Complaints in the General Population: Sleep Diary Monitoring Versus an Internet Autonomous Intervention. In Journal of Clinical Medicine, 11 (15): 4387, 2022. doi 
  15. Pouliquen, M. and Auriacombe, M. Psychotherapeutic interventions for cannabis use disorder. What do we know and what should we do?. In L'Encéphale, 48 (1): 70-77, 2022. doi 
  16. Stevens, N.; Martin-Fernandez, J.; Moriceau, S.; Serre, F.; Auriacombe, M. and Cambon, L. Realist evaluation of three programmes aimed at reducing harm and risks associated with alcohol consumption in the Nouvelle Aquitaine region of France: the ECIAE study protocol. In BMJ Open, 12 (10): e057928, 2022. doi 

2021

  1. Auriacombe, M.; Fournet, L.; Dupuy, L.; Micoulaud-Franchi, J-A.; de Sevin, E.; Moriceau, S.; Baillet, E.; Alexandre, J-M.; Serre, F. and Philip, P. Effectiveness and Acceptance of a Smartphone-Based Virtual Agent Screening for Alcohol and Tobacco Problems and Associated Risk Factors During COVID-19 Pandemic in the General Population. In Frontiers in Psychiatry, 12, 2021. doi 
  2. Bahadoor, R.; Alexandre, J-M.; Fournet, L.; Gellé, T.; Serre, F. and Auriacombe, M. Inventory and Analysis of Controlled Trials of Mobile Phone Applications Targeting Substance Use Disorders: A Systematic Review. In Frontiers in Psychiatry, 12, 2021. doi 
  3. Boisrobert, S.; Jakubiec, L.; Thevenin, J.; Diennet, P. L.; Jacquiez, O.; Mete, D.; Maechler-Durand, B.; Fatséas, M. and Auriacombe, M. Which indications for inpatient admission of a patient with an addiction? Application of the chronic disorders model. A face validity study. In Encephale, 47 (3), 2021.
  4. Boisrobert, S.; Jakubiec, L.; Thevenin, J.; Diennet, P.-L.; Jacquiez, O.; Mete, D.; Maechler-Durand, B.; Fatséas, M. and Auriacombe, M. Quelles indications d'hospitalisation d'un patient avec addiction ? Application du modèle des pathologies chroniques. Une étude de validité apparente. In L'Encéphale, 47 (3): 203-214, 2021. doi 
  5. Dupuy, L.; de Sevin, E.; Bioulac, S.; Taillard, J.; Salles, N.; Serre, F.; Auriacombe, M.; Micoulaud-Franchi, J-a. and Philip, P. Efficacité d'une TCC contre l'insomnie dispensée par un agent virtuel : Résultats pendant et après le confinement du COVID-19. In Médecine du Sommeil, 18 (1): 26, 2021. doi 
  6. Dupuy, M.; Abdallah, M.; Swendsen, J.; N'Kaoua, B.; Chanraud, S.; Schweitzer, P.; Fatseas, M.; Serre, F.; Barse, E.; Auriacombe, M. and Misdrahi, D. Real-time cognitive performance and positive symptom expression in schizophrenia. In European Archives of Psychiatry and Clinical Neuroscience, 2021. doi 
  7. Fonseca, F.; Lenahan, W.; Dart, R. C.; Papaseit, E.; Dargan, P. I.; Wood, D. M.; Guareschi, M.; Maremmani, I.; Auriacombe, M.; Farré, M.; Scherbaum, N. and Torrens, M. Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries. In Frontiers in Psychiatry, 12, 2021. doi 
  8. Grall-Bronnec, M.; Guillou-Landreat, M.; Caillon, J.; Dubertret, C.; Romo, L.; Codina, I.; Chereau-Boudet, I.; Lancon, C.; Auriacombe, M.; _, _; Hardouin, J-B. and Challet-Bouju, G. Five-year follow-up on a sample of gamblers: predictive factors of relapse. In Journal of Behavioral Addictions, 10 (1): 42-54, 2021. doi 
  9. Kervran, C.; Shmulewitz, D.; Serre, F.; Denis, C.; Roux, P.; Jauffret-Roustide, M.; Lalanne, L.; Hasin, D. and Auriacombe, M. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach. In Addictive Behaviors, 116: 106797, 2021. doi 
  10. Maremmani, I.; Hill, D.; Scherbaum, N.; Auriacombe, M.; Bacciardi, S.; Benyamina, A.; Casella, P.; D'agnone, O.; Daulouede, J. P.; Deruvo, G.; Fonseca, F.; Guareschi, M. et al. Early-readmission after agonist opioid treatment in five european countriea drug addiction health policy challenge?. In Heroin Addiction and Related Clinical Problems, 23 (4), 2021.
  11. Philip, P.; Dupuy, L.; Morin, C.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Des agents virtuels sur smartphone pour faire face aux plaintes de sommeil pendant le confinement du COVID-19 : étude de faisabilité. In Médecine du Sommeil, 18 (1): 43, 2021. doi 
  12. Ternon, A.; Dubernet, J.; Jakubiec, L.; Alexandre, J. M. and Auriacombe, M. Usage de protoxyde d'azote au sein d'une population d'étudiants en médecine. État des lieux de la consommation. Recherche de facteurs associés à cette consommation : stress lié au travail et usage problématique d'autres substances. In Therapies, 76 (2): 175, 2021. doi 

2020

  1. Beck, A.; Rosenthal, A.; Auriacombe, M. and Romanczuk-Seiferth, N. (Neuro)therapeutic Approaches in the Field of Alcohol Use Disorders. In Current Addiction Reports, 7 (3): 252-259, 2020. doi 
  2. Digé, S.; Jakubiec, L.-A. and Auriacombe, M. Les soins sans consentements peuvent-ils s'appliquer en cas d'addiction dans le contexte français ? Une analyse critique des données. In L'Encéphale, 46 (6): 471-481, 2020. doi 
  3. Kervran, C.; Shmulewitz, D.; Serre, F.; Stohl, M.; Denis, C.; Hasin, D. and Auriacombe, M. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?. In Drug and Alcohol Dependence, 212: 108036, 2020. doi 
  4. Kinouani, S.; Leflot, C.; Vanderkam, P.; Auriacombe, M.; Langlois, E. and Tzourio, C. Motivations for using electronic cigarettes in young adults: A systematic review. In Substance Abuse, 41 (3): 315-322, 2020. doi 
  5. Philip, P.; Dupuy, L.; Auriacombe, M.; Serre, F.; de Sevin, E.; Sauteraud, A. and Micoulaud-Franchi, J-A. Trust and acceptance of a virtual psychiatric interview between embodied conversational agents and outpatients. In npj Digital Medicine, 3 (1): 2, 2020. doi 
  6. Philip, P.; Dupuy, L.; Morin, C. M.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Smartphone-Based Virtual Agents to Help the General Population Concerned by Sleep Complaints During COVID-19 Confinement: A Feasibility Study (Preprint). In Journal of Medical Internet Research, 22 (12), 2020.
  7. Philip, P.; Dupuy, L.; Morin, C. M.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Smartphone-Based Virtual Agents Can Help the General Population Concerned by Sleep Complaints: A Proof-of-Concept Study During COVID-19 Confinement. In SSRN Electronic Journal, 22 (12), 2020. doi 
  8. Philip, P.; Dupuy, L.; Morin, C. M.; de Sevin, E.; Bioulac, S.; Taillard, J.; Serre, F.; Auriacombe, M. and Micoulaud-Franchi, J-A. Smartphone-Based Virtual Agents to Help Individuals With Sleep Concerns During COVID-19 Confinement: Feasibility Study. In Journal of Medical Internet Research, 22 (12): e24268, 2020. doi 

2019

  1. Auriacombe, M.; Roux, P.; Briand Madrid, L.; Kirchherr, S.; Kervran, C.; Chauvin, C.; Gutowski, M.; Denis, C.; Carrieri, M. P.; Lalanne, L. and Jauffret-Roustide, M. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol. In BMJ Open, 9 (2): e023683, 2019. doi 
  2. Benchebra, L.; Alexandre, J-M.; Dubernet, J.; Fatséas, M. and Auriacombe, M. Addiction aux jeux (d'argent et vidéo) et état de santé des joueurs : une revue critique de la littérature. In La Presse Médicale, 48 (12): 1551-1568, 2019. doi 
  3. Kaye, S.; Ramos-Quiroga, J. A.; van de Glind, G.; Levin, F. R; Faraone, S. V; Allsop, S.; Degenhardt, L.; Moggi, F.; Barta, C.; Konstenius, M.; Franck, J.; Skutle, A. et al. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. In Journal of Attention Disorders, 23 (12): 1438-1453, 2019. doi 
  4. Leouzon, H.; Alexandre, J-M.; Fatséas, M. and Auriacombe, M. L'addiction aux jeux vidéo dans le DSM-5, controverses et réponses relatives à son diagnostic et sa définition. In Annales Médico-psychologiques, revue psychiatrique, 177 (7): 610-623, 2019. doi 
  5. Micoulaud-Franchi, J-A.; Dupuy, L.; Moriceau, S.; Auriacombe, M. and Philip, P. 0922 Embodied Conversational Agents Are Highly Accepted to Diagnose Psychiatric Disorders among Patients Suffering from Sleep Disorders. In Sleep, 42 (Supplement_1): A370-A371, 2019. doi 

2018

  1. Auriacombe, M.; Fatséas, M.; Daulouède, J-P. and Tignol, J. Le craving et nouvelle clinique de l'addiction : une perspective simplifiée et opérationnelle. In Annales Médico-psychologiques, revue psychiatrique, 176 (8): 746-749, 2018. doi 
  2. Auriacombe, M.; Moriceau, S.; Serre, F.; Denis, C.; Micoulaud-Franchi, J-A.; de Sevin, E.; Bonhomme, E.; Bioulac, S.; Fatseas, M. and Philip, P. Development and validation of a virtual agent to screen tobacco and alcohol use disorders. In Drug and Alcohol Dependence, 193: 1-6, 2018. doi 
  3. Bouvard, A.; Dupuy, M.; Schweitzer, P.; Revranche, M.; Fatseas, M.; Serre, F.; Misdrahi, D.; Auriacombe, M. and Swendsen, J. Feasibility and validity of mobile cognitive testing in patients with substance use disorders and healthy controls. In The American Journal on Addictions, 27 (7): 553-556, 2018. doi 
  4. Dupouy, J.; Vergnes, A.; Laporte, C.; Kinouani, S.; Auriacombe, M.; Oustric, S. and Rougé Bugat, M-E. Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice. In European Journal of General Practice, 24 (1): 160-166, 2018. doi 
  5. Dupuy, M.; Misdrahi, D.; N'Kaoua, B.; Tessier, A.; Bouvard, A.; Schweitzer, P.; Auriacombe, M.; Serre, F.; Fatseas, M. and Swendsen, J. Mobile cognitive testing in patients with schizophrenia: A controlled study of feasibility and validity. In Journal de Thérapie Comportementale et Cognitive, 28 (4): 204-213, 2018. doi 
  6. Fatseas, M.; Serre, F.; Swendsen, J. and Auriacombe, M. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study. In Drug and Alcohol Dependence, 187: 242-248, 2018. doi 
  7. Hill, D; Scherbaum, N; Guareschi, M; Maremmani, I; McBride, K; D'Agnone, O; Ratcliffe, K; Auriacombe, M; Daulouède, J P; Villèger, P; Touzeau, D; Benyamina, A et al. Reported gabapentin and pregabalin use by patient enrolling in the opioid dependence treatment in the EUROPAD-RADARS surveillance initiative. In Heroin Addiction and Related Clinical Problems, 20, 2018.
  8. Lemasson, M.; Rochette, L.; Galvão, F.; Poulet, E.; Lacroix, A.; Lecompte, M.; Auriacombe, M.; Patry, S. and Haesebaert, F. Pertinence of Titration and Age-Based Dosing Methods for Electroconvulsive Therapy. In The Journal of ECT, 34 (4): 220-226, 2018. doi 
  9. Serre, F.; Fatseas, M.; Denis, C.; Swendsen, J. and Auriacombe, M. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. In Addictive Behaviors, 83: 123-129, 2018. doi 

2017

  1. Auriacombe, M; Apelt, SM; Scherbaum, N and Mankabady, B The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK): An Interim Report. In Value in Health, 20 (9): A716, 2017. doi 
  2. Auriacombe, M.; Alexandre, J-M.; Dubernet, J.; Tanguy, J. and Fatseas, M. Contribution of e-learning to addiction teaching: A successful experience at the university of bordeaux, France. In Drug and Alcohol Dependence, 171: e12, 2017. doi 
  3. Dematteis, M.; Auriacombe, M.; D'Agnone, O.; Somaini, L.; Szerman, N.; Littlewood, R.; Alam, F.; Alho, H.; Benyamina, A.; Bobes, J.; Daulouede, J. P.; Leonardi, C. et al. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. In Expert Opinion on Pharmacotherapy, 18 (18): 1987-1999, 2017. doi 
  4. Denis, C. M.; da Rosa, M. A. C.; Serre, F.; Kervran, C.; Henry, M.; Cherifi, B.; Auriacombe, M. and Fatseas, M. Are DSM-5 criteria for sud transferable to food addiction? IRT analysis for alcohol, tobacco, cannabis, opiate and food addiction in a clinical sample. In Drug and Alcohol Dependence, 171: e52, 2017. doi 
  5. Dupouy, J.; Palmaro, A.; Fatséas, M.; Auriacombe, M.; Micallef, J.; Oustric, S. and Lapeyre-Mestre, M. Mortalité associée aux périodes sous et hors traitement par buprénorphine. In Therapies, 72 (1): 164, 2017. doi 
  6. Dupouy, J.; Palmaro, A.; Fatséas, M.; Auriacombe, M.; Micallef, J.; Oustric, S. and Lapeyre-Mestre, M. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. In The Annals of Family Medicine, 15 (4): 355-358, 2017. doi 
  7. Fatseas, M.; Henry, M.; da Rosa, M. A. C.; Collombat, J.; Gregoire, A.; Kervran, C.; Cherifi, B. and Auriacombe, M. Eating disorder, food addiction and associated factors in obese patients. In Drug and Alcohol Dependence, 171: e62, 2017. doi 
  8. Marie Dit Asse, L.; Fabrigoule, C.; Helmer, C.; Laumon, B.; Berr, C.; Rouaud, O.; Auriacombe, S. and Lafont, S. Gender effect on driving cessation in pre-dementia and dementia phases: results of the 3C population-based study. In International Journal of Geriatric Psychiatry, 32 (10): 1049-1058, 2017. doi 
  9. Rolland, B.; Bouhassira, D.; Authier, N.; Auriacombe, M.; Martinez, V.; Polomeni, P.; Brousse, G.; Schwan, R.; Lack, P.; Bachellier, J.; Rostaing, S.; Bendimerad, P. et al. Mésusage et dépendance aux opioïdes de prescription : prévention, repérage et prise en charge. In La Revue de Médecine Interne, 38 (8): 539-546, 2017. doi 
  10. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. How psychiatric comorbidity and mood states influence craving and substance use in daily life? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorders. In Drug and Alcohol Dependence, 171: e187, 2017. doi 
  11. Techer, L.; Alexandre, J-M.; Mété, D.; Auriacombe, M. and Fatseas, M. Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory. In Drug and Alcohol Dependence, 171: e201, 2017. doi 

2016

  1. Auriacombe, M.; Debrabant, R.; Kervran, C.; Serre, F.; Taillard, J.; Philip, P.; Denis, C. and Fatséas, M. Addiction et troubles du sommeil : craving, rythmes circadiens. Une mise au point. In Médecine du Sommeil, 13 (3): 91-99, 2016. doi 
  2. Auriacombe, M; Serre, F and Fatseas, M Le craving : marqueur diagnostique et pronostique des addictions?. In Traité d'addictologie, 2016.
  3. Denis, C.; Fatséas, M.; Beltran, V.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Daulouède, J-P. and Auriacombe, M. Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling. In Substance Abuse, 37 (1): 168-175, 2016. doi 
  4. Fatséas, M.; Hurmic, H.; Serre, F.; Debrabant, R.; Daulouède, J-P.; Denis, C. and Auriacombe, M. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. In Psychiatry Research, 246: 656-662, 2016. doi 
  5. Fatseas, M.; Kervran, C. and Auriacombe, M. Troubles du sommeil et addictions : impact sur la qualité de vie et le risque de rechute. In La Presse Médicale, 45 (12): 1164-1169, 2016. doi 
  6. Lafont, S.; Marie Dit Asse, L.; Helmer, C.; Laumon, B.; Berr, C.; Rouaud, O.; Auriacombe, S. and Fabrigoule, C. Arrêt de la conduite automobile dans la pré-démence et la démence. In Revue d'Épidémiologie et de Santé Publique, 64: S205, 2016. doi 
  7. Petry, N. M; Rehbein, F.; Gentile, D. A; Lemmens, J. S; Rumpf, H-J.; Mössle, T.; Bischof, G.; Tao, R.; Fung, D. S S; Borges, G.; Auriacombe, M.; González‐Ibáñez, A. et al. Griffiths et al .'s comments on the international consensus statement of internet gaming disorder: furthering consensus or hindering progress?. In Addiction, 111 (1): 175-178, 2016. doi 
  8. Werb, D.; Garfein, R.; Kerr, T.; Davidson, P.; Roux, P.; Jauffret-Roustide, M.; Auriacombe, M.; Small, W. and Strathdee, S. A A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. In Harm Reduction Journal, 13 (1): 25, 2016. doi 

2015

  1. Alexandre, J-M.; Fatseas, M.; Bouju, G.; Legauffre, C.; Valleur, M.; Magalon, D.; Chereau-Boudet, I.; Gorsane, M.; Auriacombe, M.; Hardouin, J.; Venisse, J. and Grall-Bronnec, M. Gambling behavior among gamblers with and without attention deficit/hyperactivity disorder. In Drug and Alcohol Dependence, 146: e205-e206, 2015. doi 
  2. Auriacombe, M.; Denis, C. M.; Rosa, M. A. C.; Collombat, J.; Serre, F.; Daulouede, J-P. and Fatseas, M. Validity of the eating section for the modified addiction severity index. In Drug and Alcohol Dependence, 156: e12, 2015. doi 
  3. Daulouède, J-P.; Denis, C. M.; Fatseas, M.; Beltran, V. and Auriacombe, M. Risk-taking behavior over 36-month follow-up treatment in outpatient opioid maintenance treatment program. In Drug and Alcohol Dependence, 146: e258, 2015. doi 
  4. Denis, C. M.; Fatseas, M.; Beltran, V.; Daulouede, J-P. and Auriacombe, M. Impact of 20 years harm reduction policy on HIV and HCV among opioid users not in treatment. In Drug and Alcohol Dependence, 146: e261, 2015. doi 
  5. Duburque, C.; Canva, V.; Auriacombe, M.; Djomboue, P.; Hernout, B.; Lucidarme, D. and Harbonnier, J. A 3 year follow-up of HCV infection in opioid use disorder patients in treatment. In Drug and Alcohol Dependence, 156: e60, 2015. doi 
  6. Fatseas, M.; Collombat, J.; Rosa, M. A. C.; Denis, C. M.; Alexandre, J-M.; Debrabant, R.; Serre, F. and Auriacombe, M. Measuring “craving” in food addiction: Type, frequency, intensity. In Drug and Alcohol Dependence, 156: e66, 2015. doi 
  7. Fatseas, M; Hurmic, H.; Debrabant, R.; Serre, F and Auriacombe, M. Substance use patterns associated with adult ADHD in SUD treatment-seeking patients: Results from the aquitaine addiction cohort study. In Drug and Alcohol Dependence, 146: e274-e275, 2015. doi 
  8. Fatseas, M.; Serre, F.; Alexandre, J-M.; Debrabant, R.; Auriacombe, M. and Swendsen, J. Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. In Addiction, 110 (6): 1035-1042, 2015. doi 
  9. Hurmic, H.; Debrabant, R.; Kervran, C.; Serre, F.; Auriacombe, M. and Fatseas, M. ADHD and substance use disorders: Subtype and gender differences. In Drug and Alcohol Dependence, 156: e100-e101, 2015. doi 
  10. Hurmic, H.; Debrabant, R.; Serre, F.; Fatseas, M.; Alix, M. and Auriacombe, M. Frequency and intensity of craving among addicted patients during outpatient treatment. In Drug and Alcohol Dependence, 146: e145, 2015. doi 
  11. Kervran, C.; Debrabant, R.; Taillard, J.; Philip, P.; Auriacombe, M. and Fatseas, M. Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions. In Drug and Alcohol Dependence, 156: e108, 2015. doi 
  12. Kervran, C; Serre, F; Fatseas, M; Debrabant, R.; Trouba, C; Taillard, J; Philip, P and Auriacombe, M. Sleep quality in patients with SUD and behavioral addictions assessed by actigraphy: A prospective study. In Drug and Alcohol Dependence, 146: e156-e157, 2015. doi 
  13. Kervran, C.; Fatséas, M.; Serre, F.; Taillard, J.; Beltran, V.; Leboucher, J.; Debrabant, R.; Alexandre, J-M.; Daulouède, J-P.; Philip, P. and Auriacombe, M. Association between morningness/eveningness, addiction severity and psychiatric disorders among individuals with addictions. In Psychiatry Research, 229 (3): 1024-1030, 2015. doi 
  14. Lhommeau, N.; Alexandre, J-M.; Mete, D.; Fatseas, M. and Auriacombe, M. Characteristics of gamblers choosing self-exclusion from casinos: A prospective study in a French overseas territory. In Drug and Alcohol Dependence, 156: e127, 2015. doi 
  15. Rosa, M. A. C.; Collombat, J.; Denis, C. M.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatseas, M. Overlap between food addiction and DSM-5 eating disorders in a treatment seeking sample. In Drug and Alcohol Dependence, 156: e192, 2015. doi 
  16. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Does craving intensity influence cue exposure reports? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin use disorder. In Drug and Alcohol Dependence, 156: e201, 2015. doi 
  17. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Corrigendum to “Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review” Drug and Alcohol Dependence 148 (2015) 1–20. In Drug and Alcohol Dependence, 154: 305-314, 2015. doi 
  18. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Ecological momentary assessment in the investigation of craving and substance use in daily life: A systematic review. In Drug and Alcohol Dependence, 148: 1-20, 2015. doi 
  19. Skutle, A.; Bu, E. T. H.; Jellestad, F. K.; van Emmerik-van Oortmerssen, K.; Dom, G.; Verspreet, S.; Carpentier, P. J.; Ramos-Quiroga, J. A.; Franck, J.; Konstenius, M.; Kaye, S.; Demetrovics, Z. et al. Early developmental, temperamental and educational problems in ‘substance use disorder' patients with and without ADHD. Does ADHD make a difference?. In Addictive Behaviors Reports, 2: 13-18, 2015. doi 
  20. Wapp, M.; van de Glind, G.; van Emmerik-van Oortmerssen, K.; Dom, G.; Verspreet, S.; Carpentier, P. J.; Ramos-Quiroga, J. A.; Skutle, A.; Bu, E-T.; Franck, J.; Konstenius, M.; Kaye, S. et al. Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. In European Addiction Research, 21 (4): 188-194, 2015. doi 

2014

  1. Auriacombe, M; Denis, C and Fatseas, M Commentary on Sharkow et al. (2014): Longitudinal patterns of problematic computer game use among adolescents and adults – a 2-year panel study. Welcomed and yet to come. Are we looking at what we are looking for?. In Addiciton, 2014.
  2. Auriacombe, M.; Denis, C. M.; Beltran, V.; Alexandre, J.; Debrabant, R.; Serre, F.; Daulouede, J-P. and Fatseas, M. 10-years outcome of methadone- and buprenorphine-maintained patients. Mortality, quality of life and substance use. In Drug and Alcohol Dependence, 140: e8, 2014. doi 
  3. Debrabant, R.; Fatseas, M.; Denis, C.; Taillard, J.; Philip, P. and Auriacombe, M. Qualité subjective du sommeil chez des sujets dépendants aux opiacés traités par méthadone ou buprénorphine. In Médecine du Sommeil, 11 (1): 34-35, 2014. doi 
  4. Denis, C. M.; Fleury, B.; Nalpas, B.; Crapelet, M. and Auriacombe, M. Correlation between severity of addiction and level of services received by alcohol use disorder outpatients in France. In Drug and Alcohol Dependence, 140: e48, 2014. doi 
  5. Fatseas, F; Debrabant, R and Auriacombe, M Usage de substances psychoactives et TDA/H. In Aide Mémoire des TDA/H à tous les âges, 2014.
  6. Fleury, B.; Denis, C. M.; Nalpas, B.; Crapelet, M. and Auriacombe, M. Patient motivation and 12-month treatment outcome in alcohol use disorder outpatients in France. In Drug and Alcohol Dependence, 140: e61, 2014. doi 
  7. Gazel, C; Fatseas, M and Auriacombe, M Quels changements pour les addictions dans le DSM 5 ?. In La Lettre du Psychiatre, 10 (2): 50-53, 2014.
  8. Kervran, C.; Trouba, C.; Debrabant, R.; Taillard, J.; Philip, P. and Auriacombe, M. Qualité du sommeil chez des sujets dépendants évalués par actimétrie. In Médecine du Sommeil, 11 (1): 33, 2014. doi 
  9. Lofwall, M. R; Martin, J.; Tierney, M.; Fatséas, M.; Auriacombe, M. and Lintzeris, N. Buprenorphine Diversion and Misuse in Outpatient Practice. In Journal of Addiction Medicine, 8 (5): 327-332, 2014. doi 
  10. Petry, N. M; Blanco, C.; Auriacombe, M.; Borges, G.; Bucholz, K.; Crowley, T. J; Grant, B. F; Hasin, D. S and O'Brien, C. An Overview of and Rationale for Changes Proposed for Pathological Gambling in DSM-5. In Journal of Gambling Studies, 30 (2): 493-502, 2014. doi 
  11. Petry, N. M; Rehbein, F.; Gentile, D. A; Lemmens, J. S; Rumpf, H-J.; Mössle, T.; Bischof, G.; Tao, R.; Fung, D. S. S.; Borges, G.; Auriacombe, M.; González Ibáñez, A. et al. An international consensus for assessing internet gaming disorder using the new DSM-5 approach. In Addiction, 109 (9): 1399-1406, 2014. doi 
  12. Petry, N. M; Rehbein, F.; Gentile, D. A; Lemmens, J. S; Rumpf, H-J.; Mössle, T.; Bischof, G.; Tao, R.; Fung, D. S. S.; Borges, G.; Auriacombe, M.; GonzálezIbáñez, A. et al. Moving internet gaming disorder forward: A reply. In Addiction, 109 (9): 1412-1413, 2014. doi 
  13. Petry, N. M; Rehbein, F.; Gentile, D. A; Lemmens, J. S; Rumpf, H-J.; Mössle, T.; Bischof, G.; Tao, R.; Fung, D. S. S.; Borges, G.; Auriacombe, M.; GonzálezIbáñez, A. et al. Internet gaming and addiction: a reply to King & Delfabbro. In Addiction, 109 (9): 1567-1568, 2014. doi 
  14. Serre, F.; Fatseas, M.; Swendsen, J. and Auriacombe, M. Does craving predict substance use for different substance use disorders? An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and heroin dependence. In Drug and Alcohol Dependence, 140: e202-e203, 2014. doi 
  15. Serre, F; Fatseas, M; Swendsen, J and Auriacombe, M Are sleep disturbances associated with craving intensity?: What is the influence of psychiatric comorbidity and type of substance on this relationship? A computerized ambulatory monitoring study in patients beginning treatment for addiction. In 76th College on Problems of Drug Dependence, 2014.
  16. Serre, F; Fatséas, M; Swendsen, J; Taillard, J; Philip, P and Auriacombe, M Relation entre problèmes de sommeil et envie de consommer (craving) chez des sujets dépendants en début de prise en charge pour leur addiction. In Medecine du sommeil, 11 (34), 2014.
  17. van de Glind, G.; Konstenius, M.; Koeter, M. W.J.; van Emmerik-van Oortmerssen, K.; Carpentier, P-J.; Kaye, S.; Degenhardt, L.; Skutle, A.; Franck, J.; Bu, E-T.; Moggi, F.; Dom, G. et al. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria. In Drug and Alcohol Dependence, 134 (1): 158-166, 2014. doi 
  18. van Emmerik-van Oortmerssen, K.; van de Glind, G.; Koeter, M. W J; Allsop, S.; Auriacombe, M.; Barta, C.; Bu, E. T. H; Burren, Y.; Carpentier, P-J.; Carruthers, S.; Casas, M.; Demetrovics, Z. et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. In Addiction, 109 (2): 262-272, 2014. doi 

2013

  1. Alexandre, J M; Fatséas, M; Dubernet, J; Tanguy, J and Auriacombe, M Apports du e-learning à la formation clinique. In Santé Mentale (175): 14-17, 2013.
  2. Alho, H; Auriacombe, M; Fischer, G; Maremmani, I; Scherbaum, N and Torrens, M Can outcomes monitoring of opioid maintenance treatment be improved in Europe?: A statement by some European experts with interests in opioid maintenance treatment and its safety. In Heroin Addiction And Related Clinical Problems, 15 (1): 63-64, 2013.
  3. Aubin, H-J.; Auriacombe, M.; Reynaud, M. and Rigaud, A. Implication pour l'alcoologie de l'évolution des concepts en addictologie: De l'alcoolisme au trouble de I'usage d'alcool = Changing concepts in addiction medicine: From alcoholism to alcohol use disorder. In Alcoologie et Addictologie, 35 (4), 2013.
  4. Aubin, H-J.; Auriacombe, M.; Reynaud, M. and Rigaud, A. Implication pour l'alcoologie de l'évolution des concepts en addictologie: De l'alcoolisme au trouble de l'usage d'alcool. In Alcoologie et addictologie, 35 (4), 2013.
  5. Barrault, M M B; Barthelemy, V B; Bussieres E, E B; Lakdja F, F L; Garguil V, V G and Auriacombe M, M A Implementation of short and brief interventions for alcohol and tobacco program in surgical oncological unit: Analysis of pre and post-implementation process at 6 months. In Supportive Care in Cancer, 21, 2013.
  6. Barrault, M.; Barthélémy, V.; Garguil, V.; Auriacombe, M.; Saint-Jacques, M. and Bussieres, E. Implantation d'un dispositif de repérage et d'interventions brèves pour l'alcool et le tabac pour les patients traités pour un cancer. Résultats d'une étude pilote à six mois. In Revue d'Épidémiologie et de Santé Publique, 61, 2013.
  7. de Beaufort, D. G.; Sesay, M.; Stinus, L.; Thiebaut, R.; Auriacombe, M. and Dousset, V. P 4. Cerebral blood flow modulation by transcutaneous cranial electrical stimulation with Limoge's current. In Clinical Neurophysiology, 124 (10): e65, 2013. doi 
  8. Fatseas, M; Denis, C; Debrabant, R; Mathillon, V; Beltran, V; Daulouède, J P; Balducci, M and Auriacombe, M Changes in Sleep Quality in Opiate-Dependent Subjects in Methadone and Buprenorphine Maintenance Treatment over a 12-month period. In Heroin Addiction and Related Clinical Problems, 15 (1): 39-44, 2013.
  9. Hasin, D. S; Auriacombe, M.; Borges, G.; Bucholz, K.; Budney, A.; Crowley, T.; Grant, B. F; O'Brien, C.; Petry, N. M; Schuckit, M. and Wall, M. M The DSM-5 Field Trials and Reliability of Alcohol Use Disorder. In American Journal of Psychiatry, 170 (4): 442-443, 2013. doi 
  10. Hasin, D. S; O'Brien, C. P.; Auriacombe, M.; Borges, G.; Bucholz, K.; Budney, A.; Compton, W. M; Crowley, T.; Ling, W.; Petry, N. M; Schuckit, M. and Grant, B. F DSM-5 Criteria for Substance Use Disorders: Recommendations and Rationale. In American Journal of Psychiatry, 170 (8): 834-851, 2013. doi 
  11. Sarram, S; Debrabant, R; Fatseas, M; Daulouede, J P; Sagaspe, P; Taillard, J; Philip, P; Auriacombe, M; S., S.; R., D.; M., F.; J.P., D. et al. Changes in sleep quality and alertness in opiate-dependent subjects after stable methadone and buprenorphine maintenance treatment. A pilot exploratory report. In Heroin Addiction and Related Clinical Problems, 15 (1): 39-44, 2013.
  12. van de Glind, G.; van den Brink, W.; Koeter, M. W.J.; Carpentier, P-J.; van Emmerik-van Oortmerssen, K.; Kaye, S.; Skutle, A.; Bu, E-T. H.; Franck, J.; Konstenius, M.; Moggi, F.; Dom, G. et al. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. In Drug and Alcohol Dependence, 132 (3): 587-596, 2013. doi 

2012

  1. Alexandre, J-M.; Fatseas, M and Auriacombe, M Addiction(s)?. In Biofutur, 338: 27-29, 2012.
  2. Bosc, E.; Fatséas, M.; Alexandre, J.-M. and Auriacombe, M. Similitudes et différences entre le jeu pathologique et la dépendance aux substances : qu'en est-il ?. In L'Encéphale, 38 (5): 433-439, 2012. doi 
  3. Bosc, E; Fatséas, M; Alexandre, J.-M. and Auriacombe, M Similitudes et différences entre le jeu pathologique et la dépendance aux substances: Qu'en est-il? = Similarities and differences between pathological gambling and substance dependence: A clarification. In L'Encéphale: Revue de psychiatrie clinique biologique et thérapeutique, 38 (5), 2012.
  4. Denis, C.; Fatséas, M. and Auriacombe, M. Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of Pathological Gambling criteria. In Drug and Alcohol Dependence, 122 (1-2): 22-27, 2012. doi 
  5. Denis, C.; Fatséas, M.; Beltran, V.; Bonnet, C.; Picard, S.; Combourieu, I.; Daulouède, J-P. and Auriacombe, M. Validity of the Self-Reported Drug Use Section of the Addiction Severity Index and Associated Factors Used under Naturalistic Conditions. In Substance Use & Misuse, 47 (4): 356-363, 2012. doi 
  6. Denis, C.; Langlois, E.; Fatséas, M.; Auriacombe, M. and Auriacombe, M. Un modèle français de Communauté Thérapeutique ? Les communautés thérapeutiques expérimentales : Consensus des professionnels. In Psychotropes, Vol. 17 (3): 85-101, 2012. doi 
  7. Fatseas, M.; Debrabant, R. and Auriacombe, M. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. In Current Opinion in Psychiatry, 25 (3): 219-225, 2012. doi 
  8. Fatseas, M.; Denis, C.; Serre, F.; Dubernet, J.; Daulouède, J-P. and Auriacombe, M. Change in HIV-HCV Risk-Taking Behavior and Seroprevalence Among Opiate Users Seeking Treatment Over an 11-year Period and Harm Reduction Policy. In AIDS and Behavior, 16 (7): 2082-2090, 2012. doi 
  9. Gense de Beaufort, D.; Sesay, M; Stinus, L; Thiebaut, R; Auriacombe, M and Dousset, V Cerebral blood flow modulation by transcutaneous cranial electrical stimulation with Limoge's current. In Journal of Neuroradiology, 39 (3): 167-175, 2012. doi 
  10. Malivert, M.; Fatséas, M.; Denis, C.; Langlois, E. and Auriacombe, M. Effectiveness of Therapeutic Communities: A Systematic Review. In European Addiction Research, 18 (1): 1-11, 2012. doi 
  11. ROSSARD, P.; RIUNE-LACABE, S.; COUSIN, P.; DENIS, C. and AURIACOMBE, M. Consommation de substances et comportements à risque au cours de l'incarcération: Enquête dans une maison d'arrêt en France. In Le Courrier des addictions, 14 (2), 2012.
  12. Serre, F; Denis, C; Fatseas, M and Auriacombe, M Santé, travail et addiction. In Le Courrier des Addictions, 14: 22-23, 2012.
  13. Serre, F.; Fatseas, M.; Debrabant, R.; Alexandre, J-M.; Auriacombe, M. and Swendsen, J. Ecological momentary assessment in alcohol, tobacco, cannabis and opiate dependence: A comparison of feasibility and validity. In Drug and Alcohol Dependence, 126 (1-2): 118-123, 2012. doi 

2011

  1. Auriacombe, M Conseil pour un fumeur et son entourage non-fumeur. In Le Courrier des Addictions: 13:16, 2011.
  2. Fatseas, M.; Denis, C.; Massida, Z.; Verger, M.; Franques-Rénéric, P. and Auriacombe, M. Cue-Induced Reactivity, Cortisol Response and Substance Use Outcome in Treated Heroin Dependent Individuals. In Biological Psychiatry, 70 (8): 720-727, 2011. doi 

Collections

2018

  1. Auriacombe, M.; Serre, F.; Denis, C. and Fatséas, M. Diagnosis of Addictions. In The Routledge Handbook of Philosophy and Science of Addiction, pages 132-144, Routledge, 1 [edition]. | New York : Routledge, 2018. | Series: Routledge handbooks in philosophy, 2018.

2016

  1. Denis, C.; Alexandre, J-M.; Serre, F.; Auriacombe, M. and Fatséas, M. 38. Outils d'évaluation pour les addictions. In Traité d'addictologie, 2016.

2015

  1. Fatseas, M.; Dubernet, J.; Daoulouède, J-P. and Auriacombe, M. Buprenorphine in the Treatment of Opioid Addiction: The French Experience. In Textbook of Addiction Treatment: International Perspectives, pages 501-510, Springer Milan, Milano, 2015.

2014

  1. Auriacombe, M.; Debrabant, R. and Fatséas, M. 21. Usage de substances. In TDA/H - Trouble Déficit de l'Attention/Hyperactivité, pages 170-178, Dunod, 2014.
  2. Fatséas, M.; Denis, C. and Auriacombe, M. Chapitre 14. Héroïne et opiacés. In Addictions et comorbidités, pages 237-247, Dunod, 2014.

2013

  1. Denis, C.; Lavie, E.; Fatseas, M. and Auriacombe, M. Psychotherapeutic interventions for cannabis abuse and/or dependence in outpatient settings. In Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd, Chichester, UK, 2013.

2012

  1. Fatseas, M; Denis, C; Alexandre, J-M. and Auriacombe, M Les critères diagnostiques de la dépendance aux substances psycho-actives sont-ils valides pour le diagnostic du jeu pathologique ?. In Le jeu pathologique. Comprendre-Prévenir-Traiter, pages 101-105, Masson, Paris, Congrès de psychiatrie et de neurologie de langue française , 2012.

In Proceedings

2013

  1. Fatseas, M; Serre, F; Swendsen, J and Auriacombe, M Does cue type matter for Craving?: Comparison of substance-specific and person-specific cues using mobile technologies. In 75th College on Problems of Drug Dependence, 2013.
  2. Serre, F; Fatseas, M; M., S J and Auriacombe, M Does craving predict substance use for different substance use disorders?: Ecological Momentary Assessment in alcohol, tobacco, cannabis and heroin dependence. In 75th College on Problems of Drug Dependence, 2013.
  3. Swendsen, J; Serre, F; Fatseas, M and Auriacombe, M A systematic review of studies exploring craving, its moderators, and the link with substance use in daily life using Ecological Momentary Assessment (EMA). In 75th College on Problems of Drug Dependence, 2013.

2012

  1. Fatseas, M; Serre, F; Swendsen, J and Auriacombe, M Relationships between sleep disturbances and variations of craving in patients beginning treatment for addiction: a computerized ambulatory monitoring study. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.
  2. Quintin, J; Serre, F; Fatseas, M; Auriacombe, S and Auriacombe, M Relationships between decision making, type of addiction, and addiction severity. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.
  3. Serre, F; Swendsen, J; Fatseas, M and Auriacombe, M Feasibility and validity of Ecological Momentary Assessment in alcohol, tobacco, cannabis and opiates dependent patients. In 74th College on Problems of Drug Dependence, Palm Springs, California, 2012.

2011

  1. Beltran, V; Aguerretxe Colina, A; Maitre, C; Auriacombe, M and Daulouède, J P Comorbidités psychiatriques chez les consommateurs de tabac. Etude transversale sur les consommateurs de tabac reçus au CSAPA BIZIA à Bayonne de 2006 à 2010. In 5èmes Journées de l'Albatros, Congrès international d'Addictologie, Paris, 2011.

Misc

2015

  1. Denis, C. M.; Metzger, D.; Huang, L.; Trias, V.; Auriacombe, M.; Raguin, G.; Hoai, S. M. T.; Le Truong, G.; Daulouede, J-P. and O'Brien, C. P. A 6-month follow-up of the integrated treatment for opiate addiction and HIV in Vietnam. doi  WWW 

2014

  1. Auriacombe, M.; Denis, C. and Fatséas, M. Commentary on Scharkow etal. (2014): Welcomed and yet to come. Are we looking at what we are looking for?. doi 

 

 

 


Université de Bordeaux CNRS

CNRS UMR 6033



Participez à une étude...

A noter

L’étude OBAP (Observatoire Buprénorphine d’Action Prolongée) : Description en situation naturelle de l’introduction de la buprénorphine d’action prolongée en France : une étude prospective observationnelle (n° ID-RCB 2022-A02616-37).


Directeur

Pr. Marc Auriacombe

Directeur adjoint

J. Taillard

Administration :

Tel : +33 (0)5 57 82 01 73

Bureau Recherche Sommeil

Tel : +33 (0)5 57 82 01 82

Bureau Recherche Addiction

Tel : +33 (0)5 56 56 17 67

Adresse :

UMR 6033 SANPSY
CHU Pellegrin, Tripode
13ème étage, aile 3
Place Amélie- Raba-Léon
33076 Bordeaux cédex
France

logo SANPSY Accéder au laboratoire


Investissement d'Avenir Clinilabs Certified Site Clinilabs Certified Site